{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:05:13Z","timestamp":1784808313713,"version":"3.55.0"},"reference-count":23,"publisher":"Jaypee Brothers Medical Publishing","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.59556\/japi.74.1363","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T10:09:46Z","timestamp":1781604586000},"page":"e42-e47","source":"Crossref","is-referenced-by-count":0,"title":["Expert Consensus and Physician Perspectives on a Low-dose Triple Fixed-dose Combination for Type 2 Diabetes in India"],"prefix":"10.59556","volume":"74","author":[{"given":"Jothydev","family":"Kesavadev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AG","family":"Unnikrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banshi","family":"Saboo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shankha Shubhra","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smriti","family":"Gadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thamburaj","family":"Anthuvan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2914","reference":[{"key":"key20260723114537_B1","doi-asserted-by":"crossref","first-page":"940\u2013","DOI":"10.1016\/j.tjnut.2023.02.028","article-title":"Are unhealthy diets contributing to the rapid rise of type 2 diabetes in India?","volume":"153:","author":"Mohan","year":"2023;","journal-title":"J Nutr"},{"key":"key20260723114537_B2","doi-asserted-by":"crossref","first-page":"145\u2013","DOI":"10.4103\/jod.jod_118_21","article-title":"Expert consensus on triple combination of glimepiride, metformin, and voglibose usage in patients with type 2 diabetes mellitus in Indian settings.","volume":"13:","author":"Das","year":"2022;","journal-title":"J Diabetol"},{"key":"key20260723114537_B3","doi-asserted-by":"crossref","first-page":"5450\u2013","DOI":"10.4103\/jfmpc.jfmpc_843_20","article-title":"Fixed-dose combination in management of type 2 diabetes mellitus: Expert opinion from an international panel.","volume":"9:","author":"Kalra","year":"2020;","journal-title":"J Family Med Prim Care"},{"key":"key20260723114537_B4","doi-asserted-by":"crossref","first-page":"194\u2013","DOI":"10.1097\/01.pap.0000249909.54047.0e","article-title":"Metformin plus low-dose glimepiride significantly improves HOMA-IR and beta-cell function (HOMA-\u03b2) without hyperinsulinemia in patients with type 2 diabetes mellitus.","volume":"14:","author":"Berm\u00fadez-Pirela","year":"2007;","journal-title":"Am J Ther"},{"key":"key20260723114537_B5","doi-asserted-by":"crossref","first-page":"309.","DOI":"10.4103\/2230-8210.149334","article-title":"Starting with low dose sulfonylurea and metformin in early stage type 2 diabetes mellitus.","volume":"19:","author":"George","year":"2015;","journal-title":"Indian J Endocrinol Metab"},{"key":"key20260723114537_B6","first-page":"94\u2013","article-title":"Efficacy and safety of low dose glimepiride\u2013metformin fixed dose combination [0.5 mg glimepiride + 500 mg metformin SR] in patients with type 2 diabetes mellitus in Nepal.","volume":"153:","author":"Banset","year":"2019;","journal-title":"Indian Med Gaz"},{"key":"key20260723114537_B7","volume-title":"Williams Textbook of Endocrinology,","author":"Melmed","year":"2019.","edition":"14th edition."},{"key":"key20260723114537_B8","first-page":"8\u2013","article-title":"Usage of low-dose glimepiride (0.5 mg) and metformin combination in the management of type 2 diabetes continuum in Indian setting.","volume":"23:","author":"Jain","year":"2022;","journal-title":"Asian J Diabetol"},{"key":"key20260723114537_B9","doi-asserted-by":"crossref","first-page":"422\u2013","DOI":"10.3923\/ijp.2016.422.428","article-title":"Addition of voglibose to glimepiride and metformin has better glucose control in diabetics: A prospective, parallel-group and open-label comparative study.","volume":"12:","author":"Murti","year":"2016;","journal-title":"Int J Pharmacol"},{"issue":"(2):","key":"key20260723114537_B10","doi-asserted-by":"crossref","first-page":"88\u2013","DOI":"10.1016\/j.dsx.2015.09.021","article-title":"Retrospective comparison of voglibose or acarbose as an add-on therapy to sulfonylureas in Western Indian patients with uncontrolled overweight\/obese type 2 diabetes.","volume":"10","author":"Talaviya","year":"2016;","journal-title":"Diabetes Metab Syndr"},{"issue":"(6):","key":"key20260723114537_B11","first-page":"953\u2013","article-title":"Metformin: from mechanisms of action to therapies. Cell Metab","volume":"20","author":"Foretz","year":"2014;"},{"issue":"(9675):","key":"key20260723114537_B12","doi-asserted-by":"crossref","first-page":"1607\u2013","DOI":"10.1016\/S0140-6736(09)60222-1","article-title":"Voglibose for prevention of type 2 diabetes mellitus in Japanese individuals with impaired glucose tolerance: a randomised, double-blind trial.","volume":"373","author":"Kawamori","year":"2009;","journal-title":"Lancet"},{"key":"key20260723114537_B13","first-page":"97\u2013","article-title":"Metformin plus low glimepiride doses improve significantly HOMA-IR and HOMA-\u03b2-cell without hyperinsulinemia in patients with type 2 diabetes.","volume":"24:","author":"Berm\u00fadez","year":"2005;","journal-title":"Arch Venez Farmacol Ter"},{"key":"key20260723114537_B14","doi-asserted-by":"crossref","first-page":"213\u2013","DOI":"10.1089\/dia.2019.0484","article-title":"Comparison of glycemic excursion using flash continuous glucose monitoring in patients with type 2 diabetes mellitus before and after treatment with voglibose.","volume":"23:","author":"Kasthuri","year":"2021;","journal-title":"Diabetes Technol Ther"},{"key":"key20260723114537_B15","unstructured":"Oxford Centre for Evidence-Based Medicine. (2011). The Oxford Levels of Evidence 2. [online] Available from https:\/\/www.cebm.ox.ac.uk\/resources\/levels-of-evidence\/ocebm-levels-of-evidence [Last accessed January, 2026]."},{"issue":"((Suppl. 1):","key":"key20260723114537_B16","first-page":"S1\u2013","article-title":"American Diabetes Association. Standards of medical care in diabetes\u20142025.","volume":"48","year":"2025;","journal-title":"Diabetes Care"},{"key":"key20260723114537_B17","first-page":"52\u2013","article-title":"Reducing or discontinuing insulin or sulfonylurea when initiating a glucagon-like peptide-1 agonist.","volume":"41:","author":"Herron","year":"2024;","journal-title":"Fed Pract"},{"key":"key20260723114537_B18","doi-asserted-by":"crossref","first-page":"110742.","DOI":"10.1016\/j.diabres.2023.110742","article-title":"Prescribing trends of glucose-lowering drugs in older adults from 2010 to 2021: A population-based study of Northern Italy.","author":"Foresta","year":"2023;","journal-title":"Diabetes Res Clin Pract"},{"issue":"(9):","key":"key20260723114537_B19","first-page":"OC05\u2013","article-title":"Assessment of clinical experience of triple drug fixed-dose combination of glimepiride, metformin and voglibose in the management of type 2 diabetes mellitus: A retrospective study.","volume":"15","author":"Bantwal","year":"2021;","journal-title":"J Clin Diagn Res"},{"key":"key20260723114537_B20","doi-asserted-by":"crossref","first-page":"49\u2013","DOI":"10.13189\/adm.2016.040302","article-title":"Safety and efficacy of fixed-dose combination of voglibose, glimepiride, and metformin in Indian type 2 diabetes mellitus patients.","volume":"4:","author":"Faruqui","year":"2016;","journal-title":"Adv Diabetes Metab"},{"key":"key20260723114537_B21","first-page":"e52064.","article-title":"Observational, multicenter, retrospective study on the usage patterns of the fixed-dose combination of glimepiride, metformin, and voglibose in type 2 diabetes management.","volume":"16:","author":"Shamanna","year":"2024;","journal-title":"Cureus"},{"key":"key20260723114537_B22","unstructured":"Ministry of Health and Family Welfare. (2023). National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases & Stroke (NPCDCS). [online] Available from https:\/\/nhm.gov.in\/ [Last accessed January, 2026]."},{"key":"key20260723114537_B23","doi-asserted-by":"crossref","first-page":"10\u2013","DOI":"10.1016\/j.diabres.2012.12.001","article-title":"The double burden of diabetes and tuberculosis\u2014Public health implications.","volume":"101:","author":"Kapur","year":"2013;","journal-title":"Diabetes Res Clin Pract"}],"container-title":["Journal of The Association of Physicians of India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:45:49Z","timestamp":1784807149000},"score":1,"resource":{"primary":{"URL":"https:\/\/japi.org\/article\/japi-74-6-e42"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.59556\/japi.74.1363"],"URL":"https:\/\/doi.org\/10.59556\/japi.74.1363","relation":{},"ISSN":["0004-5772"],"issn-type":[{"value":"0004-5772","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]}}}